Majority of patients not asked for consent before being switched to a biosimilar, survey finds

17 July 2019 - The preliminary survey results showed that 52% of patients received a letter from hospital about switching to ...

Read more →

Trump to order drive for improved flu vaccine

16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...

Read more →

Drug Utilisation Sub-Committee outcome statement

17 July 2019 - The outcome statement from the June 2019 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

Pharmaceutical Benefits Scheme restrictions on anti‐epileptic drug prescribing promote unsafe and outdated practice

1 July 2019 - The PBS urgently needs to update anti‐epileptic drug prescribing restrictions that put patients and prescribers at ...

Read more →

Bev takes 14 pills a day. She's far from alone.

15 July 2019 - She is among the more than one-in-three Australians aged over 70 who take five or more different ...

Read more →

Drug Utilisation Sub-Committee utilisation analysis public release documents

12 July 2019 - The utilisation analysis public release documents from the February 2019 Drug Utilisation Sub-Committee Meeting are now available. ...

Read more →

Biosimilars continue to exhibit market failure

11 July 2019 - From their inception, biosimilars in the U.S. have faced headwinds.  ...

Read more →

Vaccine crisis leaves Australia’s immunisation record in tatters

9 July 2019 - Thousands of Australians are dying from the flu and meningococcal because lifesaving vaccines are not being approved, ...

Read more →

Patients take outdated drugs because of PBS restrictions: UQ doctor

2 July 2019 - Patients are put at risk because the restrictions on drugs made by the Pharmaceutical Benefits Scheme ...

Read more →

Forcing patients to switch to biosimilars puts them in uncharted waters

23 June 2019 - On May 27, the B.C. government announced a policy that will forcibly switch thousands of patients, ...

Read more →

How big pharma suppresses ‘biosimilars’

23 June 2019 - Deals with insurers and pharmacy benefit managers at patient and taxpayer expense. ...

Read more →

Combatting misinformation on biosimilars and preparing the market for them can save the U.S. billions

19 June 2019 - As politicians and policymakers debate effective ways to rein in rising health care costs, biosimilars represent ...

Read more →

Advisory Council supports biosimilars in call for universal public drug coverage in Canada

17 June 2019 - A Canadian advisory council is recommending the use of biosimilars in a final report that lays ...

Read more →

Government crackdown on abuse of antibiotics

17 June 2019 - Doctors could be prevented from prescribing repeats of antibiotics as authorities consider radical plans to contain ...

Read more →

Realigning incentives to optimise generic and biosimilar prescribing

13 June 2019 - Drug prices and their impact on total US health care expenditures are again front of mind ...

Read more →